Demyelinating diseases, including multiple sclerosis (MS) and Charcot-Marie-Tooth (CMT) disease, present a substantial and escalating burden. Each of these conditions afflicts approximately three ...

Quantum Biopharma has filed with the FDA to start a Phase 2 trial of Lucid-MS to assess the treatment's ability to halt ...

A genetic mutation that helps animals like yaks and Tibetan antelopes survive at high altitudes may hold the key to repairing nerve damage in conditions such as cerebral paralysis and multiple ...

Myelin is a lipid sheath that insulates nerve fibers carrying signals throughout the brain and body. When this sheath becomes damaged, the passage of these crucial signals is disrupted, leading to ...

In the coming weeks, Quantum Biopharma will seek FDA permission for a clinical trial testing Lucid-MS, its therapy to slow myelin loss in MS.

PRIME designation follows recent Breakthrough Therapy designation from the U.S. FDA, underscoring the importance and urgency of addressing optic ...

There’s a virus you may have never heard of before that is estimated to infect up to 90 percent of people and lurks quietly in your cells for life—but if it becomes activated, it will destroy your ...

Christina Applegate explained the reason behind her decision to purchase burial plots for when she dies, five years after ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for zilganersen, an ...

Eight Researchers Named Fellows of the American Association for the Advancement of Science Rutgers faculty elected to the ...

The motor components of juggling are fairly simple,” says Professor Tommy Wood, while steering apples through the air, “once ...